ADC Therapeutics SA

Go to ADC Therapeutics SA Website

$2.75

0.06 (2.04%)
Live
Previous Close

$2.69

Day Range

$2.64 - $2.785

Previous Day Range

$2.59 - $2.74

Market Cap

$302.0 million USD

Day Vol.

338609

Previous Day Vol.

669033

Currency

USD

Primary Exchange

New York Stock Exchange

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Analysts forecast the global oncology drug market to exceed $900 billion by 2034, with biotech firms like Oncolytics, Teva, Citius, ADC Therapeutics, and OS Therapies driving cancer treatment innovation amid potential NCI funding cuts.

Related tickers: ONCY, TEVA, CTOR, ADCT, OSTX.

Read Full Article

The blood cancer market is experiencing robust growth, driven by rising incidence rates and advancements in targeted therapies and immuno-oncology. Increasing adoption of CAR-T cell therapies, monoclonal antibodies, and personalized medicine is transforming treatment outcomes.

Related tickers: ABBV, SLS, MRK, AAPG, JNJ, ADCT, BMY, CELGr, REGN, RHHBY, ACLX, KROS, SYRS, BGNE, ONC.

Read Full Article
Trending Tickers

Please sign in to view